Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Holder

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Medicinal Research Reviews|March 3, 2004
Melanocortin ligands: 30 years of structure-activity relationship (SAR) studiesJerry Ryan Holder, Carrie Haskell-Luevano
Annals of the New York Academy of Sciences|July 10, 2003
Melanocortin tetrapeptides modified at the N-terminus, His, Phe, Arg, and Trp positionsJerry Ryan Holder, Carrie Haskell-Luevano
Peptides|February 11, 2003
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg positionJerry Ryan Holder, Zhimin Xiang, Rayna M Bauzo, et al.
Journal of Medicinal Chemistry|June 28, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe positionJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
Journal of Medicinal Chemistry|June 14, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His positionJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
Journal of Medicinal Chemistry|December 13, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp positionJerry Ryan Holder, Zhimin Xiang, Rayna M Bauzo, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequenceJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
IEEE Journal of Biomedical and Health Informatics|July 4, 2025
A Feature-Augmented Transformer Model to Recognize Functional Activities from in-the-wild Smartwatch DataBryan Minor, Colin Greeley, Ryan Holder, et al.
European Journal of Pharmacology|February 20, 2003
Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptorsJerry Ryan Holder, Fernanda F Marques, Zhimin Xiang, et al.
Journal of the American Society for Mass Spectrometry|September 29, 2011
Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MSHongyan Li, Mark J Rose, Jerry Ryan Holder, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Medicinal Research Reviews|March 3, 2004
Melanocortin ligands: 30 years of structure-activity relationship (SAR) studiesJerry Ryan Holder, Carrie Haskell-Luevano
Annals of the New York Academy of Sciences|July 10, 2003
Melanocortin tetrapeptides modified at the N-terminus, His, Phe, Arg, and Trp positionsJerry Ryan Holder, Carrie Haskell-Luevano
Peptides|February 11, 2003
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg positionJerry Ryan Holder, Zhimin Xiang, Rayna M Bauzo, et al.
Journal of Medicinal Chemistry|June 28, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe positionJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
Journal of Medicinal Chemistry|June 14, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His positionJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
Journal of Medicinal Chemistry|December 13, 2002
Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp positionJerry Ryan Holder, Zhimin Xiang, Rayna M Bauzo, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequenceJerry Ryan Holder, Rayna M Bauzo, Zhimin Xiang, et al.
IEEE Journal of Biomedical and Health Informatics|July 4, 2025
A Feature-Augmented Transformer Model to Recognize Functional Activities from in-the-wild Smartwatch DataBryan Minor, Colin Greeley, Ryan Holder, et al.
European Journal of Pharmacology|February 20, 2003
Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptorsJerry Ryan Holder, Fernanda F Marques, Zhimin Xiang, et al.
Journal of the American Society for Mass Spectrometry|September 29, 2011
Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MSHongyan Li, Mark J Rose, Jerry Ryan Holder, et al.
Pageof 2